As of April 2024 VBI Vaccines has a market cap of $18.01 Million. This makes VBI Vaccines the world's 7994th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $18.01 M | 29.47% |
2023 | $13.91 M | -86.22% |
2022 | $0.10 B | -83.22% |
2021 | $0.60 B | -9.55% |
2020 | $0.66 B | 170.59% |
2019 | $0.24 B | 57.94% |
2018 | $0.15 B | -42.83% |
2017 | $0.27 B | 141.58% |
2016 | $0.11 B | 19.25% |
2015 | $94.57 M | 89.08% |
2014 | $50.01 M | 8.81% |
2013 | $45.96 M | -45.75% |
2012 | $84.73 M | -60.54% |
2011 | $0.21 B | 22.54% |
2010 | $0.17 B | 615.38% |
2009 | $24.49 M | 1216.3% |
2008 | $1.86 M |
On Apr 19th, 2024 the market cap of VBI Vaccines was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Onconova Therapeutics ONTX | $20.9 M | 16.02% | ๐บ๐ธ USA |
Curis CRIS | $84.34 M | 368.12% | ๐บ๐ธ USA |
Myriad Genetics MYGN | $1.67 B | 9,190.10% | ๐บ๐ธ USA |